Targeting FANCM using the antisense oligonucleotides to treat the ALT-positive cancers

Journal article

Open access

Peer reviewed

Shakir Naji, Christopher Tong, Ashwin Ragupathi, Ming Xiao and Dong Zhang

Molecular therapy. Nucleic acids, v 36(2), 102558

10 Jun 2025

PMID: 40503178

Files and links (1)

url

https://doi.org/10.1016/j.omtn.2025.102558View

Published, Version of Record (VoR) Open

Life Sciences & Biomedicine

Medicine, Research & Experimental

Research & Experimental Medicine

Science & Technology

1 Record Views

Title: Targeting FANCM using the antisense oligonucleotides to treat the ALT-positive cancers
Creators: Shakir Naji - New York Institute of Technology
Christopher Tong - New York Institute of Technology
Ashwin Ragupathi - New York Institute of Technology
Ming Xiao - Drexel University
Dong Zhang - New York Institute of Technology
Publication Details: Molecular therapy. Nucleic acids, v 36(2), 102558
Publisher: Elsevier
Number of pages: 3
Resource Type: Journal article
Language: English
Academic Unit: School of Biomedical Engineering and Science
Web of Science ID: WOS:001499765200002
Scopus ID: 2-s2.0-105005595183
Other Identifier: 991022197434604721

This publication has contributed to the advancement of the following goals:

Source: SDGs in the Output

Data related to this publication, from InCites Benchmarking & Analytics tool: